Navigation Links
GenVec Receives Grant for Malaria Vaccine Program
Date:7/29/2009

GAITHERSBURG, Md., July 29 /PRNewswire-FirstCall/ -- GenVec, Inc. (Nasdaq: GNVC) announced today that it has received a Small Business Innovation and Research (SBIR) grant from the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) to support the company's malaria vaccine program.

(Logo: http://www.newscom.com/cgi-bin/prnh/20081205/DC50112LOGO )

"We appreciate the support this grant offers GenVec. This funding supports the advancement of GenVec technology by moving GenVec into the antigen discovery phase of vaccine development," said Dr. Joseph Bruder, head of GenVec's malaria program.

This grant, valued at approximately $600,000 over two years, will be used to identify new immunogenic antigens for malaria vaccine development. Using the funding from this grant, GenVec will be collaborating with the U.S. Naval Medical Research Center (NMRC) to apply its adenovector technology to the development of malaria vaccine candidates.

About GenVec

GenVec, Inc. is a biopharmaceutical company developing novel therapeutic drugs and vaccines. GenVec's lead product, TNFerade(TM), is currently in a pivotal clinical study (PACT) in locally advanced pancreatic cancer. TNFerade has also been and is currently being evaluated for its potential use in the treatment of several other cancers, including esophageal cancer, rectal cancer, and head and neck cancer. GenVec also uses its proprietary adenovector technology to develop vaccines for infectious diseases including HIV, malaria, foot-and-mouth disease, respiratory syncytial virus (RSV), an
'/>"/>

SOURCE GenVec, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Olympus Managed Health Care Receives Third Party Administrative License in State of Florida
2. Diplomat Specialty Pharmacy Receives Regional Good Neighbor Pharmacy Of The Year Award
3. Lilly Receives Award From National Medical Association
4. Prescient Medical Receives Frost & Sullivan Product Innovation of the Year Award
5. Assara Laser Hair Removal Centers (New York, NY) Receives 2008 New York Award for Cosmetology & Personal Hygiene Salons by the U.S.C.A.
6. Elekta CMS Software Receives FDA 510(k) Clearance for Monaco VMAT Treatment Planning Solution
7. Case Western Reserve University receives $3.7M NIH grant to study autonomic nervous system link to painful bladder syndrome
8. Texas Health Dallas Receives Double Honor From American Heart Association
9. Varian Medical Systems Receives 510(k) Clearance for Fast and Accurate Acuros(TM) Radiotherapy Treatment Planning Capability
10. Misonix Receives First Award for Forensic Equipment in China
11. Masimo Receives FDA Clearance for New Rainbow(R) Resposable(TM) Sensor System
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)Rockville, MD "Why is it that men can be bastards and women must wear pearls and smile?" wrote author Lynn Hecht Schafran. The answer, according to an article in the Journal of Vision , may lie in
(Date:12/4/2009)Outcomes same whether procedure done immediately or 3 weeks later, study shows , , FRIDAY, Dec. 4 (HealthDay News) -- Timing of surgical repair or reconstruction of multiple-ligament knee inju
(Date:12/4/2009)Move a response to pressure from federal regulators to crack down on abuse of opioid medications , , FRIDAY, Dec. 4 (HealthDay News) -- The makers of 24 different prescription painkillers on F
(Date:12/4/2009)Dr. Redlener Applauds Historic Effort but Points out Potential Risk if America,s Safety Net Programs Are Lost in Final Health Care Reform ,, NEW YORK, Dec. 4 The New England Journal of Medicine
(Date:12/4/2009)Whether the H1N1 virus will come back during winter isn,t known, CDC says, , , FRIDAY, Dec. 4 (HealthDay News) -- The number of states reporting widespread swine flu activity continued to decl
Breaking Medicine News(10 mins):Health News:Are angry women more like men? 2Health News:Timing of Multiple-Ligament Knee Surgery May Not Matter 2Health News:Makers of Powerful Painkillers Present Safety Plans 2Health News:New England Journal of Medicine Perspective by Irwin Redlener, MD, Addresses Health Care Reform 2Health News:Swine Flu Continues to Wane 2
...ich is said to prevent about 75 percent of cervica...n women already exposed to the disease causing vir...sently the human papillomavirus (HPV) has been app... that with more widespread use of the vaccine chan...
...rst on-board avian flu testing laboratories on the...er, the company confirmed Monday.// The H5N1 ...dge and the carrier USS Kitty Hawk, said Rosemary ...e US Navy over a year ago. The Japan-based S...
...linked to an increased risk of heart attacks and s... exercise caution in its use.// The federal go...ll make the drug Prexige (generic name, lumiracoxi...eased risk of heart attacks and strokes. Popul...
...ge, for a couple, appears to rise along with the f...// according to a recent report by researchers in ...nducted their study on nearly 14,000 women in Jeru...s who delivered a baby. The researchers found ther...
... that researchers have found a way to reverse musc...very kindles hope// that a cure for the human form...y of Virginia researchers said that the therapy us...egy for treatment of myotonic dystrophy by ablatin...
...top overdoses in heroin addicts. Hence many needle...roin addicts.// The news follows the deaths of at ...th fentanyl. Prevention Point Philadelphia, ...n. "If people have to rely on paramedics, more oft...
Other Medicine News:Health News:Demand for More Widespread Use of HPV Vaccine 2Health News:Demand for More Widespread Use of HPV Vaccine 3Health News:New Arthritis Drug Linked to Increased Risk of Heart Attacks 2Health News:Risk of Miscarriage Rises with Father’s Ag 2
(Date:12/4/2009)FREMONT, Calif., Dec. 4 Vermillion, Inc. (VRML) (Pink Sheets: VRMLQ) announced that on December 3, 2009, it filed its First Amended Plan of Reorganization and related amended Disclosure Statement wit
(Date:12/4/2009)OMAHA, Neb., Dec. 4 Amber Pharmacy announced today that it received accreditation by the Accreditation Commission for Health Care, Inc. (ACHC) for specialized pharmacy services. For nearly 15 years,
(Date:12/4/2009)DURHAM, N.C., Dec. 4 Oxygen Biotherapeutics, Inc. (OTC Bulletin Board: OXBT) today announced that the first patient has been enrolled in the company,s Phase II-b, dose escalation, clinical trial in S
Breaking Medicine Technology:Vermillion Files Amended Plan of Reorganization and Exchanges Debt 2Vermillion Files Amended Plan of Reorganization and Exchanges Debt 3Amber Pharmacy Earns Accreditation From ACHC 2Oxygen Biotherapeutics, Inc. Enrolls First Patient in Traumatic Brain Injury Clinical Trial in Switzerland 2Beginning Swim Classes Too Advanced for Many Beginners 3B Swim Instructor Conference Slated 50151 1Beginning Swim Classes Too Advanced for Many Beginners 3B Swim Instructor Conference Slated 50151 2Syngenta and Evogene to Collaborate on Soybean Nematode Resistance 12799 1Syngenta and Evogene to Collaborate on Soybean Nematode Resistance 12799 2Register to Win a Ski Weekend and Make Your Synthesis Easier with EasyMax 26amp 3B 238482 3B 3A the First Automated Chemistry Development Tool That Re 12796 1Register to Win a Ski Weekend and Make Your Synthesis Easier with EasyMax 26amp 3B 238482 3B 3A the First Automated Chemistry Development Tool That Re 12796 2
...G-9200 is a Windows 2000 PC based EEG with high pe... and software. EEG-9200 provides high quality perf...in the sleep lab or EEG lab. Quality EEG recording...CU. Neurofax has high performance, high sensitivit...
...act is the first magnetic stimulator to offer the ... stimulation. It is designed to provide the simple...tic routine (at the same time, it may also help re...ons without moving away from your patient). , ,...
Fidelity IAB Intra-Aortic Balloon Catheter
...series is a new top-line range of digital pacemake...rillation (AF). Because the T-series combines digi...reatment of AF is taken one step further. Thanks t...ored continuously and extensively. This gives phys...
Medicine Products: